betaxolol has been researched along with flunarizine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chidlow, G; Cupido, A; Melena, J; Osborne, NN; Wood, JP | 1 |
| Comoglu, S; Elhan, AH; Köz, OG; Kural, G; Yarangümeli, A | 1 |
3 other study(ies) available for betaxolol and flunarizine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Topical flunarizine reduces IOP and protects the retina against ischemia-excitotoxicity.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Calcium; Calcium Channel Blockers; Choline O-Acetyltransferase; Electroretinography; Excitatory Amino Acid Agonists; Flunarizine; Intraocular Pressure; N-Methylaspartate; Neuroprotective Agents; Nifedipine; Parvalbumins; Rabbits; Rats; Rats, Wistar; Reperfusion Injury; Retina; RNA, Messenger; Sodium; Thy-1 Antigens; Vasodilator Agents | 2002 |
Effects of betaxolol and flunarizine on visual fields and intraocular pressure in patients with migraine.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Betaxolol; Calcium Channel Blockers; Drug Therapy, Combination; Female; Flunarizine; Humans; Intraocular Pressure; Male; Middle Aged; Migraine Disorders; Visual Fields | 2003 |